{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:44:47Z","timestamp":1790718287261,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023RC130"],"award-info":[{"award-number":["2023RC130"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22278104"],"award-info":[{"award-number":["22278104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jconrel.2025.114255","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:12:47Z","timestamp":1758575567000},"page":"114255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["ApoE-Corona oncolytic adenovirus nanoparticles enable blood\u2013brain barrier penetration for glioblastoma immunotherapy"],"prefix":"10.1016","volume":"387","author":[{"given":"Tong","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aodi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longcai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangren","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhou","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114255_bb0005","doi-asserted-by":"crossref","first-page":"1118246","DOI":"10.3389\/fimmu.2023.1118246","article-title":"Oncolytic immunovirotherapy for high-grade gliomas: a novel and an evolving therapeutic option","volume":"14","author":"Asija","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","article-title":"Clinical trial links oncolytic immunoactivation to survival in glioblastoma","volume":"vol. 623","author":"Ling","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114255_bb0015","doi-asserted-by":"crossref","first-page":"1285113","DOI":"10.3389\/fimmu.2023.1285113","article-title":"Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma","volume":"14","author":"Hu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0020","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.abk3436","article-title":"Oncolytic virotherapy as immunotherapy","volume":"374","author":"Melcher","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114255_bb0025","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.cell.2019.01.051","article-title":"SnapShot: Cancer immunotherapy with oncolytic viruses","volume":"176","author":"Gujar","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114255_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40425-018-0458-z","article-title":"Oncolytic virus immunotherapy: future prospects for oncology","volume":"6","author":"Raja","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114255_bb0035","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3389\/fimmu.2018.00866","article-title":"Oncolytic viral therapy and the immune system: a double-edged sword against Cancer","volume":"9","author":"Marelli","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004167","article-title":"Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment","volume":"10","author":"Wang","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114255_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/v15020547","article-title":"Recent developments in glioblastoma therapy: oncolytic viruses and emerging future strategies","volume":"15","author":"Hamad","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2025.114255_bb0050","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.annonc.2021.03.197","article-title":"Oncolytic virus in gliomas: a review of human clinical investigations","volume":"32","author":"Carpenter","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1637","article-title":"Nanomedicine and drug delivery systems in cancer and regenerative medicine","volume":"12","author":"Garbayo","year":"2020","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0060","doi-asserted-by":"crossref","first-page":"10492","DOI":"10.1073\/pnas.1919755117","article-title":"Machine learning predicts the functional composition of the protein corona and the cellular recognition of nanoparticles","volume":"117","author":"Ban","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114255_bb0065","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1021\/acsnano.8b03500","article-title":"Evolution of nanoparticle protein corona across the blood-brain Barrier","volume":"vol. 12","author":"Cox","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114255_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111527","article-title":"Protein corona components of polyethylene glycol-conjugated organosilica nanoparticles modulates macrophage uptake","volume":"199","author":"Kim","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.114255_bb0075","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1021\/acsami.9b15910","article-title":"Corona of thorns: the surface chemistry-mediated protein Corona perturbs the recognition and immune response of macrophages","volume":"12","author":"Cai","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.114255_bb0080","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.8b05265","article-title":"Apolipoprotein E peptide-directed chimeric Polymersomes mediate an ultrahigh-efficiency targeted protein therapy for glioblastoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114255_bb0085","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1021\/acs.nanolett.9b04683","article-title":"Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy","volume":"20","author":"Liu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114255_bb0090","first-page":"482","article-title":"In situ apolipoprotein E-enriched corona guides dihydroartemisinin-decorating nanoparticles towards LDLr-mediated tumor-homing chemotherapy, Asian","volume":"15","author":"Li","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114255_bb0095","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1021\/ja010452r","article-title":"Different mechanisms of oxidative stress and neurotoxicity for Alzheimer\u2019s A beta(1--42) and A beta(25--35)","volume":"123","author":"Varadarajan","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114255_bb0100","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/s41467-019-11593-z","article-title":"Brain-targeted drug delivery by manipulating protein corona functions","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114255_bb0105","article-title":"From adsorption to covalent bonding: apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood-brain barrier","volume":"4","author":"Hartl","year":"2021","journal-title":"Adv. Ther. (Weinh.)"},{"key":"10.1016\/j.jconrel.2025.114255_bb0110","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0115","first-page":"813","article-title":"Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors","volume":"61","author":"Douglas","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114255_bb0120","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1021\/acsnano.8b08964","article-title":"Erythroliposomes: integrated hybrid nanovesicles composed of erythrocyte membranes and artificial lipid membranes for pore-forming toxin clearance","volume":"13","author":"He","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114255_bb0125","doi-asserted-by":"crossref","first-page":"102078","DOI":"10.1016\/j.xcrm.2025.102078","article-title":"Tailoring an intravenously injectable oncolytic virus for augmenting radiotherapy","volume":"6","author":"Xu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jconrel.2025.114255_bb0130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41551-024-01224-4","article-title":"Reinforcement of the intestinal mucosal barrier via mucus-penetrating PEGylated bacteria","volume":"8","author":"Chen","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114255_bb0135","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.1093\/nar\/gkz687","article-title":"Adenovirus major core protein condenses DNA in clusters and bundles, modulating genome release and capsid internal pressure","volume":"47","author":"Martin-Gonzalez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2025.114255_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303567","article-title":"A cholesterol metabolic regulated hydrogen-bonded organic framework (HOF)-based biotuner for antibody non-dependent immunotherapy tailored for glioblastoma","volume":"35","author":"Yin","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114255_bb0145","doi-asserted-by":"crossref","first-page":"20210089","DOI":"10.1002\/EXP.20210089","article-title":"Advanced bioactive nanomaterials for biomedical applications","volume":"1","author":"Zhao","year":"2021","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.jconrel.2025.114255_bb0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2545","article-title":"Immunogenic and tolerogenic cell death","volume":"9","author":"Green","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biomaterials.2018.02.033","article-title":"Necroptotic cancer cells-mimicry nanovaccine boosts anti-tumor immunity with tailored immune-stimulatory modality","volume":"164","author":"Kang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114255_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217079","article-title":"Emerging role of immunogenic cell death in cancer immunotherapy: advancing next-generation CAR-T cell immunotherapy by combination","volume":"598","author":"Zhou","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.114255_bb0165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15548627.2022.2069437","article-title":"Autophagy in age-related macular degeneration","volume":"19","author":"Kaarniranta","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.jconrel.2025.114255_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2025.114255_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122913","article-title":"Targeted sonodynamic therapy induces tumor cell quasi-immunogenic ferroptosis and macrophage immunostimulatory autophagy in glioblastoma","volume":"315","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114255_bb0180","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41392-023-01683-2","article-title":"Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114255_bb0185","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymthe.2022.08.021","article-title":"CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114255_bb0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2024.11.014","article-title":"Targeting molecular pathways to control immune checkpoint inhibitor toxicities","volume":"46","author":"Reschke","year":"2025","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0195","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-killer cells and dendritic cells: \"l'union fait la force\"","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.114255_bb0200","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41593-024-01786-1","article-title":"A single-cell mass cytometry-based atlas of the developing mouse brain","volume":"28","author":"Van Deusen","year":"2025","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114255_bb0205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2025.114255_bb0210","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Martinez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114255_bb0215","article-title":"Immune response recalibration using immune therapy and biomimetic nano-therapy against high-grade gliomas and brain metastases","volume":"20","author":"Sandhbor","year":"2025","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114255_bb0220","article-title":"Dual-targeted novel temozolomide nanocapsules encapsulating siPKM2 inhibit aerobic glycolysis to sensitize glioblastoma to chemotherapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114255_bb0225","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/neuonc\/noae160","article-title":"The emerging field of viroimmunotherapy for pediatric brain tumors","volume":"26","author":"Garcia-Moure","year":"2024","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2025.114255_bb0230","doi-asserted-by":"crossref","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","article-title":"Biomimetic macrophage membrane-camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma","volume":"17","author":"Cao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114255_bb0235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jconrel.2025.114255_bb0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0245","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2025.114255_bb0250","doi-asserted-by":"crossref","first-page":"18787","DOI":"10.1073\/pnas.0604011103","article-title":"Blocking the apolipoprotein E\/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease","volume":"103","author":"Sadowski","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114255_bb0255","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nnano.2017.61","article-title":"Nanomedicine: evolution of the nanoparticle corona","volume":"12","author":"Hadjidemetriou","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0260","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/ja107583h","article-title":"Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles","volume":"133","author":"Monopoli","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114255_bb0265","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1038\/s41467-022-33044-y","article-title":"In situ analysis of nanoparticle soft corona and dynamic evolution","volume":"13","author":"Baimanov","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114255_bb0270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41698-024-00717-4","article-title":"Therapeutic approaches to modulate the immune microenvironment in gliomas","volume":"8","author":"Sarantopoulos","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0275","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","article-title":"Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma","volume":"386","author":"Gallego Perez-Larraya","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114255_bb0280","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","article-title":"Intratumoral oncolytic herpes virus G47\u2206 for residual or recurrent glioblastoma: a phase 2 trial","volume":"28","author":"Todo","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114255_bb0285","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163447","article-title":"Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment","volume":"133","author":"Arrieta","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114255_bb0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/neuonc\/noae193","article-title":"Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?","volume":"27","author":"Du","year":"2025","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2025.114255_bb0295","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114255_bb0300","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:00:42Z","timestamp":1780477242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925008673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":60,"alternative-id":["S0168365925008673"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114255","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ApoE-Corona oncolytic adenovirus nanoparticles enable blood\u2013brain barrier penetration for glioblastoma immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114255"}}